Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
By Jeffrey A. Bridge, S. Iyengar, C. Salary, R. Barbe, B. Birmaher, Harold Alan Pincus, Lulu Ren, D. Brent. Journal of the American Medical Association (JAMA), 2007
934 citations recorded by the source corpus.
Subfields: Clinical Psychology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/34afdae8bc07101721d289a3feeacd474719eefe
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Clinical Psychology
In Psychiatry and Mental health
Citations in the corpus
- Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines (2015, background): “58% response, NNT 14) (Bridge et al., 2007); however, studies of fluoxetine did show similar significant benefit in both age groups (NNT 5).”
- Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders (2014, neutral): “9%) [1302].”
- Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. (2007, methodology): “, slow metabolizers or variations in genetic polymorphisms) are related to increased risk of suicidality (Apter et al., 2006; Brent, 2004; Bridge et al., 2007; Hammad et al., 2006; Safer and Zito, 2006).”